189 related articles for article (PubMed ID: 10672299)
1. Prolactin secreting pituitary adenomas: analysis of 429 surgically treated patients, effect of adjuvant treatment modalities and review of the literature.
Ozgen T; Oruckaptan HH; Ozcan OE; Acikgoz B
Acta Neurochir (Wien); 1999; 141(12):1287-94. PubMed ID: 10672299
[TBL] [Abstract][Full Text] [Related]
2. Pituitary adenomas: results of 684 surgically treated patients and review of the literature.
Oruçkaptan HH; Senmevsim O; Ozcan OE; Ozgen T
Surg Neurol; 2000 Mar; 53(3):211-9. PubMed ID: 10773251
[TBL] [Abstract][Full Text] [Related]
3. Diagnosis and drug therapy of prolactinoma.
Ciccarelli E; Camanni F
Drugs; 1996 Jun; 51(6):954-65. PubMed ID: 8736617
[TBL] [Abstract][Full Text] [Related]
4. The outcome of hypophysectomy for prolactinomas in the era of dopamine agonist therapy.
Soule SG; Farhi J; Conway GS; Jacobs HS; Powell M
Clin Endocrinol (Oxf); 1996 Jun; 44(6):711-6. PubMed ID: 8759184
[TBL] [Abstract][Full Text] [Related]
5. Clinical and histological correlations in prolactinomas, with special reference to bromocriptine resistance.
Delgrange E; Sassolas G; Perrin G; Jan M; Trouillas J
Acta Neurochir (Wien); 2005 Jul; 147(7):751-7; discussion 757-8. PubMed ID: 15971099
[TBL] [Abstract][Full Text] [Related]
6. Combined treatment of invasive giant prolactinomas.
Yu C; Wu Z; Gong J
Pituitary; 2005; 8(1):61-5. PubMed ID: 16411070
[TBL] [Abstract][Full Text] [Related]
7. Five years follow-up of invasive prolactinomas with special reference to the control of cavernous sinus invasion.
Wu ZB; Su ZP; Wu JS; Zheng WM; Zhuge QC; Zhong M
Pituitary; 2008; 11(1):63-70. PubMed ID: 17917811
[TBL] [Abstract][Full Text] [Related]
8. Prolactin secreting pituitary carcinoma.
Petterson T; MacFarlane IA; MacKenzie JM; Shaw MD
J Neurol Neurosurg Psychiatry; 1992 Dec; 55(12):1205-6. PubMed ID: 1479402
[TBL] [Abstract][Full Text] [Related]
9. [Treatment of prolactinoma].
Nadalon S; De Buhan B; Archambeaud-Mouveroux F; Fournier MP; Huc MC; Laubie B
Rev Med Interne; 1990; 11(2):172-80. PubMed ID: 2204979
[TBL] [Abstract][Full Text] [Related]
10. [Bromocriptine treatment of invasive giant prolactinomas prior to comprehensive treatments: results of a long-term follow up].
Zhang HW; Yu CJ; Sun W; Yang J; Yan CX; Cun EH
Zhonghua Wai Ke Za Zhi; 2006 Nov; 44(22):1555-7. PubMed ID: 17359664
[TBL] [Abstract][Full Text] [Related]
11. Surgery, dopamine agonist therapy of combined treatment--results in prolactinoma patients after a 12 month follow-up.
Hildebrandt G; Bauer T; Stracke H; Fassbender WJ; Mueller HW; Agnoli AL; Federlin K; Roosen K
Zentralbl Neurochir; 1992; 53(3):123-34. PubMed ID: 1414079
[TBL] [Abstract][Full Text] [Related]
12. Rapid re-enlargement of a macroprolactinoma after initial shrinkage in a young woman treated with bromocriptine.
Adler I; Barsi P; Czirják S; Varga I; Gergics P; Jakab C; Rácz K
Gynecol Endocrinol; 2005 Jun; 20(6):317-21. PubMed ID: 16019380
[TBL] [Abstract][Full Text] [Related]
13. The neurosurgical management of prolactinomas.
Gökalp HZ; Deda H; Attar A; Uğur HC; Arasil E; Egemen N
J Neurosurg Sci; 2000 Sep; 44(3):128-32. PubMed ID: 11126446
[TBL] [Abstract][Full Text] [Related]
14. Surgery combined with dopamine agonists versus dopamine agonists alone in long-term treatment of macroprolactinoma: a retrospective study.
Höfle G; Gasser R; Mohsenipour I; Finkenstedt G
Exp Clin Endocrinol Diabetes; 1998; 106(3):211-6. PubMed ID: 9710362
[TBL] [Abstract][Full Text] [Related]
15. Clinical practice. Prolactinomas.
Klibanski A
N Engl J Med; 2010 Apr; 362(13):1219-26. PubMed ID: 20357284
[No Abstract] [Full Text] [Related]
16. Medical management of prolactin-secreting pituitary adenomas.
Molitch ME
Pituitary; 2002; 5(2):55-65. PubMed ID: 12675502
[TBL] [Abstract][Full Text] [Related]
17. Malignant growth of a recurrent macroprolactinoma after radiation therapy.
Rainov NG; Burkert W
Neurochirurgia (Stuttg); 1993 Sep; 36(5):172-5. PubMed ID: 8272171
[TBL] [Abstract][Full Text] [Related]
18. Giant prolactinomas: clinical management and long-term follow up.
Shrivastava RK; Arginteanu MS; King WA; Post KD
J Neurosurg; 2002 Aug; 97(2):299-306. PubMed ID: 12186457
[TBL] [Abstract][Full Text] [Related]
19. Combined surgery and radiotherapy of invasive pituitary adenomas--problems of radiogenic encephalopathy.
Rauhut F; Stolke D
Acta Neurochir Suppl; 1996; 65():37-40. PubMed ID: 8738492
[TBL] [Abstract][Full Text] [Related]
20. Management of resistant prolactinomas.
Olafsdottir A; Schlechte J
Nat Clin Pract Endocrinol Metab; 2006 Oct; 2(10):552-61. PubMed ID: 17024154
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
